Reinforcement Learning in Diabetes Mellitus Trial

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 4, 2021

Primary Completion Date

January 4, 2022

Study Completion Date

January 28, 2022

Conditions
Diabetes Mellitus, Type 2Medication Adherence
Interventions
BEHAVIORAL

Reinforcement Learning

Participants in the intervention arm will receive up to daily, tailored text messages based on their electronic pill bottle-measured adherence. Given the participants' baseline characteristics and time-varying responses to the messages, a reinforcement learning algorithm will deliver different text messages and adapt over time to determine which type of messaging works best for each individual participant.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT04473326 - Reinforcement Learning in Diabetes Mellitus Trial | Biotech Hunter | Biotech Hunter